Introducing ATLASLearn more
Legal Opinion

Forest Laboratories Inc. v. Torrent Pharmaceuticals Ltd.

United States Judicial Panel on Multidistrict Litigation

Decided June 12, 2012No. MDL No. 2364Published

1Opinion of the Court

TRANSFER ORDER

JOHN G. HEYBURN II, Chairman.

Before the Panel: * Pursuant to 28 U.S.C. § 1407, plaintiffs Forest Laboratories, Inc., and Forest Laboratories Holdings, Ltd. (collectively Forest) have moved to centralize this litigation in the District of Delaware. This litigation currently consists of two actions pending, respectively, in the District of Delaware and the Northern District of Illinois.

Responding defendants in the Delaware action1 do not oppose centralization. Watson Laboratories defendants2 in the Dela*1355ware action take no position on centralization but suggest selection of the…

2Cases cited4 opinions

  1. In Re Brimonidine Patent LitigationUnited States Judicial Panel on Multidistrict Litigation · 2007
  2. In Re Metoprolol Succinate Patent Lit.United States Judicial Panel on Multidistrict Litigation · 2004
  3. In Re ALFUZOSIN HYDROCHLORIDE PATENT LITIGATIONUnited States Judicial Panel on Multidistrict Litigation · 2008
  4. In Re Armodafinil Patent LitigationUnited States Judicial Panel on Multidistrict Litigation · 2010

Showing a preview — retrieve the full document via the Exa API.

View API DocsGet API Key

Powered by the Exa API